Novel predictive role for mid-regional proadrenomedullin in moderate to severe aortic stenosis
ESJ Tan, YY Oon, SP Chan, OW Liew, JPC Chong… - Heart, 2022 - heart.bmj.com
Objective We investigated the prognostic significance of selected known and novel
circulating biomarkers in aortic stenosis (AS). Methods N-terminal pro-BNP (NT-proBNP) …
circulating biomarkers in aortic stenosis (AS). Methods N-terminal pro-BNP (NT-proBNP) …
Midregional proadrenomedullin improves risk stratification beyond surgical risk scores in patients undergoing transcatheter aortic valve replacement
A Csordas, F Nietlispach, P Schuetz, A Huber… - PLoS …, 2015 - journals.plos.org
Background Conventional surgical risk scores lack accuracy in risk stratification of patients
undergoing transcatheter aortic valve replacement (TAVR). Elevated levels of midregional …
undergoing transcatheter aortic valve replacement (TAVR). Elevated levels of midregional …
Mid-regional pro-adrenomedullin (MR-proADM) and mid-regional pro-atrial natriuretic peptide (MR-proANP) in severe aortic valve stenosis: association with outcome …
G Baldenhofer, M Laule, M Mockel… - Clinical Chemistry and …, 2017 - degruyter.com
Background: This study aimed to assess the association of mid-regional (MR) pro-
adrenomedullin (MR-proADM) and MR-pro-A-type natriuretic peptide (MR-proANP) in …
adrenomedullin (MR-proADM) and MR-pro-A-type natriuretic peptide (MR-proANP) in …
Midregional Proadrenomedullin for Prediction of Cardiovascular Events in Coronary Artery Disease: Results from the AtheroGene Study
Abstract BACKGROUND Midregional proadrenomedullin (MR-proADM) is a newly identified
prognostic marker in heart failure. We evaluated the prognostic impact of MR-proADM in a …
prognostic marker in heart failure. We evaluated the prognostic impact of MR-proADM in a …
Prognostic potential of midregional pro‐adrenomedullin following decompensation for systolic heart failure: comparison with cardiac natriuretic peptides
C Morbach, A Marx, M Kaspar, G Gueder… - European journal of …, 2017 - Wiley Online Library
Aims Whereas guidelines recommend the routine use of natriuretic peptides (NPs) in heart
failure (HF) care, the clinical relevance and prognostic potential of midregional pro …
failure (HF) care, the clinical relevance and prognostic potential of midregional pro …
Influence of age on the prognostic value of mid-regional pro-adrenomedullin in the general population
Objective Experimental studies have shown that adrenomedullin (ADM) has an important
role in circulatory homeostasis. Mid-regional pro-ADM (MR-proADM) is a stable form of …
role in circulatory homeostasis. Mid-regional pro-ADM (MR-proADM) is a stable form of …
Circulating midregional proadrenomedullin and risk of incident abdominal aortic aneurysm: A prospective longitudinal cohort study
S Acosta, A Gottsäter, G Engström, O Melander… - …, 2018 - journals.sagepub.com
Prospective clinical plasma biomarker studies in abdominal aortic aneurysm (AAA)
pathogenesis have been hampered by the need for very large cohorts and long follow-up …
pathogenesis have been hampered by the need for very large cohorts and long follow-up …
Mid‐region pro‐adrenomedullin adds predictive value to clinical predictors and Framingham risk score for long‐term mortality in stable outpatients with heart failure
Aims The aim of this study was to evaluate the long‐term prognostic utility of mid‐region
prohormone adrenomedullin (MR‐proADM) in stable outpatients with heart failure (HF) …
prohormone adrenomedullin (MR‐proADM) in stable outpatients with heart failure (HF) …
Midregional proadrenomedullin and its change predicts recurrent major coronary events and heart failure in stable coronary heart disease patients: the LIPID study
A Funke-Kaiser, K Mann, D Colquhoun, T Zeller… - International journal of …, 2014 - Elsevier
Background Biomarkers may contribute to risk stratification in coronary heart disease (CHD).
We examined whether plasma midregional proadrenomedullin (MR-proADM) concentration …
We examined whether plasma midregional proadrenomedullin (MR-proADM) concentration …
Influence of confounding factors on plasma mid-regional pro-adrenomedullin and mid-regional pro-A-type natriuretic peptide concentrations in healthy individuals
SS Bhandari, JE Davies, J Struck, LL Ng - Biomarkers, 2011 - Taylor & Francis
Background: MRproADM and MRproANP can be used as diagnostic and prognostic
markers in heart failure. Aim: The objective was to identify confounding factors for the …
markers in heart failure. Aim: The objective was to identify confounding factors for the …